In a breakthrough clinical trial, Stanford University researchers have created a never-before-seen vaccine that utilizes modified DNA to shut down specific sections of the immune system. The vaccine has shown promising results in combatting Type 1 diabetes, potentially paving the way for brand new treatments to help individuals with the disorder.

Read more